LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus

LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus

Abstract Background Enzybiotics are promising alternatives to conventional antibiotics for drug-resistant infections. Exolysins, as a class of enzybiotics, show antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). This study evaluated a novel exolysin containing an SH3b...

Full description

Bibliographic Details
Main Authors: Marzieh Asadi, Mortaza Taheri-Anganeh, Maryam Ranjbar, Seyyed Hossein Khatami, Amir Maleksabet, Zohreh Mostafavi-Pour, Younes Ghasemi, Abdolkhalegh Keshavarzi, Amir Savardashtaki
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Microbiology
Subjects:
Staphylococcus aureus
SH3b domain
Enzybiotic
MRSA
Exolysin
Online Access:https://doi.org/10.1186/s12866-023-03002-9

Internet

https://doi.org/10.1186/s12866-023-03002-9

Similar Items